DOI: 10.1056/NEJMoa0909747
PT-141, Sermorelin, GHK-Cu, and NAD+ Combination Treatment Protocol March 13, 2025 15:33 Category Name Content Name PT-141, Sermorelin, GHK-Cu, and NAD+ Combination Therapy Uses A multi-peptide and coenzyme therapy designed to enhance sexual function, stimulate growth hormone release, improve skin and hair health, and optimize cellular energy production
The growing popularity of GLP-1 receptor agonistssuch as Ozempic and Mounjaro for diabetes, and Wegovy and Zepbound for weight managementhas sparked both excitement and concern
GHK-Cu is a naturally occurring copper-binding tripeptide that your body produces and uses as a repair signal
Semaglutide is 100% FDA-approved for weight loss In addition to the wealth of clinical literature available publicly (much, but definitely not all, of which we covered above), patients should rest easy knowing that semaglutide has the full backing of the FDA the first such endorsement granted by the administration since 2014